Evidence map›Paper›PMID 42668845›Full record

ArticleCureus2026

Rare Presentation of Parsonage-Turner Syndrome Post Tdap Vaccination: A Case Report.

Matthew Jervis, Anastasie Dunn-Pirio

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Matthew JervisMedicine, California University of Science and Medicine, Colton, USA.
Anastasie Dunn-PirioNeurosciences, University of California San Diego, San Diego, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parsonage-Turner Syndrome (PTS) is a rare disorder of the brachial plexus typically characterized by acute shoulder and/or upper extremity pain, followed by muscle weakness. Though the specific etiology of PTS is unclear, numerous associations are cited in the literature, including after routine vaccinations. A previously healthy 22-year-old male developed subacute left upper extremity weakness and numbness < 24 hours following a routine Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) booster vaccination, later evolving into diffuse weakness and sharp shoulder pain. Electromyography (EMG) findings were suggestive of early PTS, and subsequent magnetic resonance imaging (MRI) of the brachial plexus confirmed mild inflammatory changes consistent with brachial plexitis. Over several months, the patient showed clinical improvement with conservative management. This case highlights a rare presentation of post-vaccination PTS, emphasizing the need for early recognition and supportive management. Although rare, clinicians should consider PTS in patients presenting with acute-onset upper extremity pain and weakness following vaccination.

Indexed as

brachial neuritisbrachial plexopathycase reportneurologyparsonage-turner syndromeperipheral neuropathy

Identifiers

PMID42668845
PMCPMC13525781

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.